IL112489A0 - Cyclic neurokinin a antagonists - Google Patents

Cyclic neurokinin a antagonists

Info

Publication number
IL112489A0
IL112489A0 IL11248995A IL11248995A IL112489A0 IL 112489 A0 IL112489 A0 IL 112489A0 IL 11248995 A IL11248995 A IL 11248995A IL 11248995 A IL11248995 A IL 11248995A IL 112489 A0 IL112489 A0 IL 112489A0
Authority
IL
Israel
Prior art keywords
antagonists
neurokinin
cyclic
cyclic neurokinin
antagonism
Prior art date
Application number
IL11248995A
Other languages
English (en)
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL112489A0 publication Critical patent/IL112489A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL11248995A 1994-02-03 1995-01-31 Cyclic neurokinin a antagonists IL112489A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/191,571 US5521156A (en) 1994-02-03 1994-02-03 Cyclic neurokinin A antagonists

Publications (1)

Publication Number Publication Date
IL112489A0 true IL112489A0 (en) 1995-03-30

Family

ID=22706020

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11248995A IL112489A0 (en) 1994-02-03 1995-01-31 Cyclic neurokinin a antagonists

Country Status (19)

Country Link
US (1) US5521156A (no)
EP (1) EP0741743B1 (no)
JP (2) JPH09511490A (no)
KR (3) KR100380873B1 (no)
CN (1) CN1139931A (no)
AT (1) ATE172205T1 (no)
AU (1) AU691246B2 (no)
CA (1) CA2182486C (no)
DE (1) DE69505351T2 (no)
DK (1) DK0741743T3 (no)
ES (1) ES2123234T3 (no)
FI (1) FI963074A0 (no)
HU (1) HUT74383A (no)
IL (1) IL112489A0 (no)
MX (1) MX9603194A (no)
NO (1) NO963255L (no)
NZ (1) NZ279595A (no)
WO (1) WO1995021187A1 (no)
ZA (1) ZA95710B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830863A (en) * 1988-06-20 1998-11-03 Merrell Pharmaceuticals Inc. Neurokinin A antagonists
US5744120A (en) * 1993-03-30 1998-04-28 The Dupont Merick Pharmaceutical Company Ternary radiopharmaceutical complexes
US5521156A (en) * 1994-02-03 1996-05-28 Merrell Pharmaceuticals Inc. Cyclic neurokinin A antagonists
US5879659A (en) * 1996-03-13 1999-03-09 Dupont Pharmaceuticals Company Ternary radiopharmaceutical complexes
MX9709494A (es) * 1996-12-04 1998-07-31 Pfizer Compuestos peptidicos ciclicos, procedimiento para su produccion, composiciones que los contienen y uso de los mismos.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4102877A (en) * 1976-07-28 1978-07-25 Merck & Co., Inc. Cyclization of peptides
US4659691A (en) * 1985-02-08 1987-04-21 Merck & Co., Inc. Novel cyclic Hexapeptide LHRH antagonists
IT1233696B (it) * 1989-05-29 1992-04-14 Menarini Farma Ind Peptidi di sintesi antagonisti della neurochinina a. loro sali e relativi procedimenti di fabbricazione
IT1241761B (it) * 1990-08-03 1994-02-01 Menarini Farma Ind Peptidi di sintesi antagonisti della neurochinina a, loro sali e relativi procedimenti di fabbricazione
DK0528312T3 (da) * 1991-08-13 1997-12-29 Takeda Chemical Industries Ltd Cykliske peptider og anvendelse deraf
US5521156A (en) * 1994-02-03 1996-05-28 Merrell Pharmaceuticals Inc. Cyclic neurokinin A antagonists

Also Published As

Publication number Publication date
ES2123234T3 (es) 1999-01-01
HUT74383A (en) 1996-12-30
AU691246B2 (en) 1998-05-14
DK0741743T3 (da) 1999-06-23
JPH09511490A (ja) 1997-11-18
ZA95710B (en) 1995-10-16
CN1139931A (zh) 1997-01-08
DE69505351D1 (de) 1998-11-19
KR100380872B1 (ko) 2003-04-18
CA2182486C (en) 2002-10-08
ATE172205T1 (de) 1998-10-15
CA2182486A1 (en) 1995-08-10
WO1995021187A1 (en) 1995-08-10
NZ279595A (en) 1997-12-19
FI963074A (fi) 1996-08-02
HU9602157D0 (en) 1996-09-30
NO963255D0 (no) 1996-08-02
NO963255L (no) 1996-10-02
AU1677195A (en) 1995-08-21
FI963074A0 (fi) 1996-08-02
DE69505351T2 (de) 1999-06-02
KR100380873B1 (ko) 2003-04-18
MX9603194A (es) 1997-05-31
KR100378726B1 (ko) 2003-10-04
US5521156A (en) 1996-05-28
EP0741743A1 (en) 1996-11-13
EP0741743B1 (en) 1998-10-14
JP2005089471A (ja) 2005-04-07

Similar Documents

Publication Publication Date Title
TR200001603T2 (tr) Yeni bileşikler
MX9605128A (es) Nuevos derivados de aminoacidos, procedimientos para su preparacion y composiciones farmaceuticas que contienen estos compuestos.
MX9705414A (es) Antagonistas de vasopresina triciclicos.
HU9503826D0 (en) Heterocycles useful as neurokinin antagonists
EG18081A (en) Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as the use indurugs
MX9702307A (es) Pirrolo (2,3-d)pirimidinas y su uso.
BG103096A (en) Thrombin inhibitors
NO893431D0 (no) Fremgangsmaate for fremstilling av neuropeptid y antagonister.
MX9801890A (es) Nuevos compuestos antagonistas selectivos del receptor nk3 humano, procedimiento para su obtencion y composiciones farmaceuticas que los contienen.
MX9701955A (es) Antagonistas de neuroquinina.
AU1667500A (en) N-(2-phenyl-4-piperidinybutyl)-5,6,7,8-tetrahydro-1-naphthal necarboxamides and their use as neurokinin 1 (nk1) and/or neurokinin 2 (nk2) receptor antagonists
TR199700834T1 (xx) 1-Aril-2-Akilamino ethan bile�ikleri ve bunlar�n n�rokinin olarak �zellikle n�rokinin 1 has�mlar� olarak kullan�mlar�.
MX9704050A (es) P-amidinobencilamidas de dipeptido novedosas con radicales sulfonilo o aminosulfonilo en terminal n.
TR199900363T2 (xx) NK1 ve NK2 antagonistleri olarak asilaminoalkenilen-amid t�revleri.
HU9602157D0 (en) Cyclic neurokinin a antagonists
CA2022740A1 (en) Cyclic neurokinin a antagonists
EP0347802A3 (en) Neurokinin a antagonists
MX9603199A (es) Antagonistas de receptores a endotelina.
DE69805988D1 (de) Herstellung von 1,3-diaminopentan durch hydrierung von 3-aminopentanitril
NZ330464A (en) Methods for the preparation of biphenyl isoxazole sulfonamides
TR200000602T2 (tr) Yeni karbonik asit türevleri, üretimleri ve kullanımları.
IE862569L (en) Decapeptide antagonists of neurokinin b